Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.06% shed 0.13% to $163.62 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.01% rising 0.51% to 4,246.44 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.68% rising 0.20% to 33,945.58. Johnson & Johnson closed $10.03 short of its 52-week high ($173.65), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -1.14% fell 1.26% to $375.20, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.32% fell 0.73% to $76.19, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.51% rose 0.48% to $39.61. Trading volume (5.5 M) remained 1.7 million below its 50-day average volume of 7.2 M.